In silico techniques for the identification of bioisosteric replacements for drug design

Current Topics in Medicinal Chemistry

Volumn 10, Issue 6, 2010, Pages 657-668

  Devereux, Mike ^a,b   Popelier, Paul L A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; MOLECULAR SCAFFOLD;

ALGORITHM; BIOISOSTERISM; CHEMINFORMATICS; COMPUTER MODEL; DRUG DESIGN; DRUG STRUCTURE; INFORMATION SCIENCE; PROCESS OPTIMIZATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTUM CHEMISTRY; REVIEW; VALIDATION PROCESS;

COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DATABASES, FACTUAL; DRUG DESIGN; MODELS, MOLECULAR; PHARMACEUTICAL PREPARATIONS;

EID: 77950933432     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802610791111470     Document Type: Review

References (97)

1. Lima, L. M. A.; Barreiro, E. J. Bioisosterism: A useful strategy for molecular modification and drug design. Curr. Med. Chem., 2005, 12, 23-49.
2. Patani, G. A.; LaVoie, E. J. Bioisosterism: A rational approach in drug design. Chem. Rev., 1996, 96, 3147-3176.
3. Thornber, C. W. Isosterism and molecular modification in drug design. Chem. Soc. Rev., 1979, 8, 563-580.
4. Hazeldine, S. T.; Polin, L.; Kushner, J.; White, K.; Bouregeois, N. M.; Crantz, B.; Palomino, E.; Corbett, T. H.; Horwitz, J. P. II. Synthesis and biological evaluation of some bioisosteres and congeners of the antitumor agent, 2-{4- (7-chloro-2-quinoxalinyl) oxy phenoxy}propionic acid (XK469). J. Med. Chem., 2002, 45, 3130-3137.
5. Gohlke, H.; Gundisch, D.; Schwarz, S.; Seitz, G.; Tilotta, M. C.; Wegge, T. Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo 4.2.1 non-2-ene UB-165. J. Med. Chem., 2002, 45, 1064-1072.
6. Lima, P. C.; Lima, L. M.; da Silva, K. C. M.; Leda, P. H. O.; de Miranda, A. L. P.; Fraga, C. A. M.; Barreiro, E. J. Synthesis and analgesic activity of novel N-acylarylhydrazones and isosters, derived from natural safrole. Eur. J. Med. Chem., 2000, 35, 187-203.
7. van Vliet, L. A.; Rodenhuis, N.; Dijkstra, D.; Wikstrom, H.; Pugsley, T. A.; Serpa, K. A.; Meltzer, L. T.; Heffner, T. G.; Wise, L. D.; Lajiness, M. E.; Huff, R. M.; Svensson, K.; Sundell, S.; Lundmark, M. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D-3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n- propyl-2H,5H- 1 benzopyra no 4,3-b -1,4-oxazin-9-ol (PD 128907). J. Med. Chem., 2000, 43, 2871-2882.
8. Mederski, W.; Osswald, M.; Dorsch, D.; Anzali, S.; Christadler, M.; Schmitges, C. J.; Wilm, C. Endothelin antagonists: Evaluation of 2,1,3-benzothiadiazole as a methylendioxyphenyl bioisoster. Bioorg. Med. Chem. Lett., 1998, 8, 17-22.
9. Krier, M.; Hutter, M. C. Bioisosteric similarity of molecules based on structural alignment and observed chemical replacements in drugs. J. Chem. Inf. Mode., 2009, 49, 1280-1297.
10. BROOD - OpenEye Scientific Software Inc., S. F., New Mexico, USA, 2006.
11. Devereux, M.; Popelier, P. L. A.; McLay, I. M. Quantum Isostere database: a web-based tool using quantum chemical topology to predict bioisosteric replacements for drug design. J. Chem. Inf. Model., 2009, 49, 1497-1513.
12. Ertl, P. World Wide Web-based system for the calculation of substituent parameters and substituent similarity searches. J. Mol. Graph. Model., 1998, 16, 11-13.
13. Holliday, J. D.; Jelfs, S. P.; Willett, P.; Gedeck, P. Calculation of intersubstituent similarity using R-group descriptors. J. Chem. Inf. Comput. Sci., 2003, 43, 406-411.
14. Gleeson, P.; Bravi, G.; Modi, S.; Lowe, D. ADMET rules of thumb II: A comparison of the effects of common substituents on a range of ADMET parameters. Bioorg. Med. Chem., 2009, 17, 5906-5919.
15. Leach, A. G.; Jones, H. D.; Cosgrove, D. A.; Kenny, P. W.; Ruston, L.; MacFaul, P.; Wood, J. M.; Colclough, N.; Law, B. Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure. J. Med. Chem., 2006, 49, 6672-6682.
16. Sheridan, R. P. The most common chemical replacements in drug-like compounds. J. Chem. Inf. Comput.Sci., 2002, 42, 103-108.
17. Ertl, P. Cheminformatics analysis of organic substituents: identification of the most common substituents, calculation of substituent properties, and automatic identification of drug-like bioisosteric groups. J. Chem. Inf.Comput. Sciences, 2003, 43, 374-380.
18. Martin, E. J.; Blaney, J. M.; Siani, M. A.; Spellmeyer, D. C.; Wong, A. K.; Moos, W. H. Measuring diversity - experimental-design of combinatorial libraries for drug discovery. J. Med. Chem., 1995, 38, 1431-1436.
19. Sayle, R.; Nicholls, A. Electrostatic evaluation of isosteric analogues. J. Comput.-Aided Mol. Design, 2006, 20, 191-208.
20. Birchall, K.; Gillet, V. J.; Willett, P.; Ducrot, P.; Luttmann, C. Use of reduced graphs to encode bioisosterism for similarity-based virtual screening. J. Chem. Inf. Model., 2009, 49, 1330-1346.
21. Lewell, X. Q.; Jones, A. C.; Bruce, C. L.; Harper, G.; Jones, M. M.; Mclay, L. M.; Bradshaw, J. Drug rings database with web interface. A tool for identifying alternative chemical rings in lead discovery programs. J. Med. Chem., 2003, 46, 3257-3274.
22. Ertl, P.; Jelfs, S.; Mühlbacher, J.; Schuffenhauer, A.; Selzer, P. Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds. J. Med. Chem., 2006, 49, 4568-4573.
23. Leach, A. R.; Green, D. V. S.; Hann, M. M.; Judd, D. B.; Good, A. C. Where are the GaPs? A rational approach to monomer acquisition and selection. J. Chem. Inf. Comput. Sci., 2000, 40, 1262-1269.
24. Derwent-Information; 2/96 ed. WDI: World Drug Index. 1996.
25. Bader, R. F. W. Atom in Molecules. A Quantum Theory; Oxford University Press, Oxford, 1990.
26. Popelier, P. L. A. Atoms in Molecules. An Introduction.; Pearson Education: London, Great Britain, 2000.
27. Devereux, M.; Popelier, P. L. A.; McLay, I. M. Toward an Ab initio fragment database for bioisosterism: dependence of qct properties on level of theory, conformation, and chemical environment. J. Comp. Chem., 2009, 30, 1300-1318.
28. Devereux, M.; Popelier, P. L. A.; McLay, I. M. A refined model for prediction of hydrogen bond acidity and basicity parameters from quantum chemical molecular descriptors. Phys.Chem. Chem. Phys., 2009, 11, 1595-1603.
29. Wagener, M.; Lommerse, J. P. M. The quest for bioisosteric replacements. J. Chem. Inf. Model., 2006, 46, 677-685.
30. Ujvary, I. BIOSTER-A database of structurally analogous compounds. Pesticide Sci., 1997, 51, 92-95.
31. Reid, D.; Sadjad, B. S.; Zsoldos, Z.; Simon, A. LASSO-ligand activity by surface similarity order: a new tool for ligand based virtual screening. J. Comput. Aided Mol. Des., 2008, 22, 479-487.
32. Talete-srl; 2.1 ed. Milan, Italy.
33. Tripos-Associates; 6.7 ed. St. Louis, MO, USA.
34. Accelrys; v.4.7 ed. San Diego, CA, USA.
35. Accelrys; v.3.3 ed. TSAR, San Diego, CA, USA.
36. Toropov, A. A.; Toropova, A. P.; Benfenati, E.; Leszczynska, D.; Leszczynski, J. SMILES-based optimal descriptors: QSAR analysis of fullerene-based HIV-1 PR inhibitors by means of balance of correlations. J. Comp. Chem., 2010, 31, 381-392
37. Karelson, M.; Lobanov, V. S.; Katritzky, A. R. Quantum-chemical descriptors in QSAR/QSPR studies. Chem. Rev., 1996, 96, 1027-1043.
38. Katritzky, A. R.; Gordeeva, E. V. Traditional topological indices vs electronic, Geometrical, and combined molecular descriptors in QSAR/QSPR research. J. Chem. Inf. Comp. Sc., 1993, 33, 835-857.
39. Popelier, P. L. A.; Smith, P. J. QSAR models based on quantum topological molecular similarity. Eur. J. Med. Chem., 2006, 41, 862-873.
40. Lamarche, O.; Platts, J. A.; Hersey, A. Theoretical prediction of partition coefficients via molecular electrostatic and electronic properties. J. Chem. Inf. Comput. Sci., 2004, 44, 848-855.
41. Kennewell, E. A.; Willett, P.; Ducrot, P.; Luttmann, C. Identification of target-specific bioisosteric fragments from ligand-rotein crystallographic data. J. Comput. Aided Mol. Des., 2006, 20, 385-394.
42. Hansch, C.; Leo, A. Exploring QSAR, American Chemical Society, 1995.
43. Nicholls, A.; MacCuish, N. E.; MacCuish, J. D. Variable selection and model validation of 2D and 3D molecular descriptors. J. Comp. Aided Mol. Des., 2004, 18, 451-474.
44. Hopfinger, A. J.; Wang, S.; Tokarski, J. S.; Jin, B. Q.; Albuquerque, M.; Madhav, P. J.; Duraiswami, C. Construction of 3D-QSAR models using the 4D-QSAR analysis formalism. J. Am. Chem. Soc., 1997, 119, 10509-10524.
45. Pastor, M.; Cruciani, G.; McLay, I.; Pickett, S.; Clementi, S. GRid-INdependent descriptors (GRIND): A novel class of alignment-ndependent three-dimensional molecular descriptors. J. Med. Chem., 2000, 43, 3233-3243.
46. Silverman, B. D.; Platt, D. E. Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition. J. Med.Chem., 1996, 39, 2129-2140.
47. Andersson, P. M.; Sjostrom, M.; Wold, S.; Lundstedt, T. In: 6th Scandinavian Symposium on Chemometrics, John Wiley & Sons Ltd: Porsgrunn, Norway, 1999, Vol.14, pp. 629-642.
48. Kalgutkar, A. S.; Gardner, I.; Obach, R. S.; Shaffer, C. L.; Callegari, E.; Henne, K. R.; Mutlib, A. E.; Dalvie, D. K.; Lee, J. S.; Nakai, Y.; O'Donnell, J. P.; Boer, J.; Harriman, S. P. A comprehensive listing of bioactivation pathways of organic functional groups. Curr. Drug Metabol., 2005, 6, 161-225.
49. Cramer, R. D.; Poss, M. A.; Hermsmeier, M. A.; Caulfield, T. J.; Kowala, M. C.; Valentine, M. T. Prospective identification of biologically active structures by topomer shape similarity searching. J. Med. Chem., 1999, 42, 3919-3933.
50. Masek, B. B.; Merchant, A.; Matthew, J. B. Molecular shape comparison of angiotensin-II receptor antagonists. J. Med. Chem., 1993, 36, 1230-1238.
51. Grant, J. A.; Pickup, B. T. A Gaussian description of molecular shape. J. Phys. Chem., 1995, 99, 3503-3510.
52. Masek, B. B.; Merchant, A.; Matthew, J. B. Molecular Skins - a New concept for quantitative shape-matching of a protein with its small-molecule mimics. Proteins, 1993, 17, 193-202.
53. Schuffenhauer, A.; Gillet, V. J.; Willett, P. In: 5th Interntional Conference on Chemical Structures, American Chemical Society: Noordwijkerhout, Netherlands, 1999, Vol.40, pp. 295-307.
54. Lauri, G.; Bartlett, P. A. In: Molecular-Graphics-Society Annual Meeting on Molecular Graphics and Design of Bioactive Molecules; Escom. Sci. Publ. Bv., Interlaken, Switzerland, 1993, Vol.8, pp. 51-66.
55. Haigh, J. A.; Pickup, B. T.; Grant, J. A.; Nicholls, A. Small molecule shape-fingerprints J.Chem. Inf. Model., 2005, 45, 673-684.
56. Schuur, J. H.; Selzer, P.; Gasteiger, J. The coding of the three-dimensional structure of molecules by molecular transforms and its application to structure-spectra correlations and studies of biological activity. J. Chem. Inf. Comput. Sci., 1996, 36, 334-344.
57. Shaik, M. S.; Devereux, M.; Popelier, P. L. A. The importance of multipole moments when describing water and hydrated amino acid cluster geometry. Mol. Phys., 2008, 106, 1495-1510.
58. Devereux, M.; Plattner, N.; Meuwly, M. Application of multipolar charge models and molecular dynamics simulations to study stark shifts in inhomogeneous electric fields. J. Phys. Chem. A, 2009, 113, 13199-13209.
59. Plattner, N.; Meuwly, M. Higher order multipole moments for molecular dynamics simulations. J. Mol. Model., 2009, 15, 687-694.
60. Cheeseright, T.; Mackey, M.; Rose, S.; Vinter, A. In: 7th International Conference on Chemical Structures; American Chemical Soc: Noordwijkerhout, Netherlands, 2005; Vol.46, pp. 665-676.
61. Anzali, S.; Gerhard, B.; Krug, M.; Wagener, M.; Gasteiger, J. In: Computer-Assisted Lead Finding and Optimization. van de Waterbeemd, H.; Testa, B.; Folkers, G.; Eds.; Helvetica Chimica Acta: Basel, 1997, pp. 95-106.
62. Tversky, A. Features of similarity. Psychol. Rev., 1977, 84, 327-352.
63. Leach, A. R.; Gillet, V. J. An Introduction to Cheminformatics; Kluwer Academic Publishers: Dordrecht, The Netherlands, 2003.
64. Smith, R.; Hubbard, R. E.; Gschwend, D. A.; Leach, A. R.; Good, A. C. Analysis and optimization of structure-based virtual screening protocols (3). New methods and old problems in scoring function design. J. Mol. Graph. Model., 2003, 22, 41-53.
65. Senger, S. Using tversky similarity searches for core hopping: finding the needles in the haystack. J. Chem. Inf. Model., 2009, 49, 1514-1524.
66. Zhang, Q.; Muegge, I. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: Ranking, voting, and consensus scoring. J. Med. Chem., 2006, 49, 1536-1548.
67. ChemApps, A.; info@altoris.com: www.chemapps.com, Altoris, San Diego, CA, USA, 2007.
68. Symyx Solutions Inc.: MDL Drug Data Report, 2007.
69. Haubertin, D. Y.; Bruneau, P. A database of historically-observed chemical replacements. J. Chem. Inf. Model., 2007, 47, 1294-1302.
70. Weininger, D.; Weininger, A.; Weininger, J. L. SMILES .2. Algprithm for generation of unique SMILES notation. J. Chem. Inf. Comput. Sci., 1989, 29, 97-101.
71. Daylight Theory: SMARTS-A Language for Describing Molecular Patterns. http://www.daylight.com/dayhtml/doc/theory/theory.smarts.html [accessed March 18, 2010].
72. Bruno, I. J.; Cole, J. C.; Lommerse, J. P. M.; Rowland, R. S.; Taylor, R.; Verdonk, M. L. IsoStar: a library of information about nonbonded interactions. J. Comput. Aided Mol. Des., 1997, 11, 525-537.
73. Allen, F. H.; Davies, J. E.; Galloy, J. J.; Johnson, O.; Kennard, O.; Macrae, C. F.; Mitchell, E. M.; Mitchell, G. F.; Smith, J. M.; Watson, D. G. The development of version-3 and version-4 of the Cambridge Structural Database system. J. Chem. Inf. Comput. Sc., 1991, 31, 187-204.
74. Bernstein, F. C.; Koetzle, T. F.; Williams, G. J. B.; Meyer, E. F.; Brice, M. D.; Rodgers, J. R.; Kennard, O.; Shimanouchi, T.; Tasumi, M. Protein Data Bank - Computer-based archival file for macromolecular structures. J. Mol. Biol., 1977, 112, 535-542.
75. Stone, A. G.; Dullweber, A.; Engkvist, O.; Fraschini, E.; Hodges, M. P.; Meredith, A. W.; Nutt, D. R.; Popelier, P. L. A.; Wales, D. J. Oreint. University of Cambridge, Enquiries to Stone, A.J. ajs@cam.ac.uk, 2002.
76. Watson, P.; Willett, P.; Gillet, V. J.; Verdonk, M. L. Calculating the knowledge-based similarity of functional groups using crystallographic data. J. Comput. Aided Mol. Des., 2001, 15, 835-857.
77. Weber, A.; Teckentrup, A.; Briem, H. Flexsim-R: A virtual affinity fingerprint descriptor to calculate similarities of functional groups. J. Comput. Aided Mol. Des., 2002, 16, 903-916.
78. Rarey, M.; Kramer, B.; Lengauer, T.; Klebe, G. A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol., 1996, 261, 470-489.
79. Stewart, K. D.; Shiroda, M.; James, C. A. Drug Guru: A computer software program for drug design using medicinal chemistry rules. Bioorg. Med. Chem., 2006, 14, 7011-7022.
80. Daylight, Daylight Chemical Information Systems Inc., Web Site: http://www.daylight.com
81. Bergmann, R.; Liljefors, T.; Sorensen, M. D.; Zamora, I. SHOP: Receptor-based scaffold hopping by grid-based similarity searches. J. Chem. Inf. Model., 2009, 49, 658-669.
82. Bergmann, R.; Linusson, A.; Zamora, I. SHOP: Scaffold HOPping by GRID-based similarity searches. J. Med. Chem., 2007, 50, 2708-2717.
83. Dey, F.; Caflisch, A. Fragment-based de novo ligand design by multiobjective evolutionary optimization. J. Chem. Inf. Model., 2008, 48, 679-690.
84. Ji, H. T.; Stanton, B. Z.; Igarashi, J.; Li, H. Y.; Martasek, P.; Roman, L. J.; Poulos, T. L.; Silverman, R. B. Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors. J. Am. Chem. Soc., 2008, 130, 3900-3914.
85. Quintus, F.; Sperandio, O.; Grynberg, J.; Petitjean, M.; Tuffery, P. Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity. BMC Bioinformatics, 2009, 10, 245.
86. Kinnings, S. L.; Jackson, R. M. LigMatch: A Multiple structure-based ligand matching method for 3d virtual screening. J. Chem. Inf. Model., 2009, 49, 2056-2066.
87. Schneider, G.; Neidhart, W.; Giller, T.; Schmid, G. "Scaffold- hopping" by topological pharmacophore search: A contribution to virtual screening. Angew. Chem.-Int. Ed., 1999, 38, 2894-2896.
88. Momany, F. A.; Rone, R. Validation of the general purpose QUANTA 3.2/CHARMm force field. J. Comput. Chem., 1992, 13, 888-900.
89. Irwin, J. J.; Shoichet, B. K. ZINC - A free database of commercially available compounds for virtual screening. J. Chem. Inf. Model., 2004, 45, 177-182.
90. Combiglide http://www.schrodinger.com/products/14/2/, [last accessed 20 Feb 2010].
91. Mauser, H.; Guba, W. Recent developments in de novo design and scaffold hopping. Curr. Opin. Drug Discov. Dev., 2008, 11, 365-374.
92. Brown, N.; Jacoby, E. On scaffolds and hopping in medicinal chemistry. Mini-Rev. Med. Chem., 2006, 6, 1217-1229.
93. Anzali, S.; Mederski, W. W. K. R.; Osswald, M.; Dorsch, D. Endothelin antagonists: search for surrogates of methylendioxypenyl by means of a kohonen neural network. Bioorg. Med. Chem. Lett., 1998, 8, 11-16.
94. Bohacek, R. S.; McMartin, C.; Guida, W. C. The art and practice of structure-based drug design: A molecular modeling perspective. Med. Res. Rev., 1996, 16, 3-50.
95. Weininger, D. In: Encyclopedia of Computational Chemistry; Schleyer, P. v. R., Allinger, N. L.; Clark, T.; Gasteiger, J.; Kollman, P. A.; Schaefer III, H. F.; Schreiner, P. R.; Eds.; John Wiley & Sons: Chichester, UK, 1998, Vol.1, pp. 425-430.
96. Pitt, W. R.; Parry, D. M.; Perry, B. G.; Groom, C. R. Heteroaromatic rings of the future. J. Med. Chem., 2009, 52, 2952-2963.
97. Nicolaou, C. A.; Apostlolakis, J.; Pattichis, C. S. De novo drug design using multiobjective evolutionary graphs. J. Chem. Inf. Model., 2009, 49, 295-307.